ARTICLE | Clinical News
CGX-1160 regulatory update
September 5, 2005 7:00 AM UTC
FDA granted Orphan Drug designation to CGX-1160 for the intrathecal treatment of neuropathic pain associated with spinal cord injury. The broad spectrum non-opioid analgesic has completed a Phase Ib t...